Last updated on December 2018

Korean Post-marketing Surveillance for Xeljanz


Brief description of study

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Clinical Study Identifier: NCT02984020

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Division of Rheumatology
Seongnam-si, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

CHA Bundang Medical Center
Seongnam-si, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

Chosun University Hospital, Rheumatism Department
Dong Gu, Korea, Republic of
9.83miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.